Zuckerman Jesse, Coburn Natalie, Callum Jeannie, Mahar Alyson L, Lin Yulia, Turgeon Alexis F, McLeod Robin, Pearsall Emily, Martel Guillaume, Hallet Julie
Division of General Surgery, Department of Surgery, University of Toronto, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Canada.
Division of General Surgery, Department of Surgery, University of Toronto, Canada; Institute of Health Policy, Management, and Evaluation, University of Toronto, Canada; Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Canada; Evaluative Clinical Sciences, Sunnybrook Research Institute, Toronto, Canada.
Surgery. 2023 Feb;173(2):392-400. doi: 10.1016/j.surg.2022.09.014. Epub 2022 Nov 3.
Patients undergoing gastrointestinal cancer surgery often receive packed red blood cell transfusions. Understanding practice variation is critical to support efforts working toward responsible transfusion use. We measured the extent and importance of variation in perioperative packed red blood cell transfusion use across physicians and hospitals among gastrointestinal cancer surgery patients.
We identified patients who underwent elective gastrointestinal cancer resection between 2007 and 2019 using linked administrative health data sets in Ontario, Canada. We used funnel plots to describe variation in transfusion use, adjusted for patient case mix. Hierarchical regression models quantified patient-level, between-physician, and between-hospital variation in transfusion use with R measures, variance partition coefficients, and median odds ratios.
Of 59,964 included patients (median age 69 years; 43.2% female; 75.8% colorectal resections), 18.0% received perioperative packed red blood cell transfusions. Funnel plots showed variation in transfusion use among physicians and hospitals. Patient characteristics, such as age, comorbidity, and procedure type, combined to explain 12.8% of the variation. After adjusting for case mix, systematic between-physician and between-hospital differences were responsible for 2.8% and 2.1% of the variation, respectively. This translated to an approximately 30% difference in the odds of transfusion for 2 similar patients treated by distinct physicians (median odds ratio: 1.35, 95% confidence interval 1.30-1.40) and hospitals (median odds ratio: 1.30, 95% confidence interval 1.23-1.42). We observed comparable effects across procedure-type subgroups.
Transfusion provision is highly driven by patient factors. Yet the impact of the treating physician and hospital on variation relative to other factors is important and reflects opportunities to target modifiable processes of care to standardize perioperative packed red blood cell transfusion practice.
接受胃肠道癌手术的患者常接受浓缩红细胞输血。了解实践差异对于支持合理输血使用的努力至关重要。我们测量了胃肠道癌手术患者中,医生和医院之间围手术期浓缩红细胞输血使用差异的程度和重要性。
我们利用加拿大安大略省的关联行政健康数据集,确定了2007年至2019年间接受择期胃肠道癌切除术的患者。我们使用漏斗图来描述输血使用情况的差异,并对患者病例组合进行了调整。分层回归模型用R测量值、方差分解系数和中位数优势比,对患者层面、医生之间以及医院之间输血使用的差异进行了量化。
纳入的59964例患者(中位年龄69岁;43.2%为女性;75.8%为结直肠癌切除术)中,18.0%接受了围手术期浓缩红细胞输血。漏斗图显示了医生和医院之间输血使用情况的差异。年龄、合并症和手术类型等患者特征共同解释了12.8%的差异。在调整病例组合后,医生之间和医院之间的系统性差异分别占差异的2.8%和2.1%。这意味着,由不同医生(中位数优势比:1.35,95%置信区间1.30 - 1.40)和医院(中位数优势比:1.30,95%置信区间1.23 - 1.42)治疗的2名相似患者,输血几率大约相差30%。我们在各手术类型亚组中观察到了类似的效果。
输血供应受患者因素的高度驱动。然而,相对于其他因素,主治医生和医院对差异的影响很重要,这反映出有机会针对可改变的护理流程,以规范围手术期浓缩红细胞输血实践。